ICONACY™ Orthopedic Implants, LLC Receives Food and Drug Administration Clearance to Market I-HIP™ Auxiliary Liners
Warsaw, IN July 2, 2014 ICONACY Orthopedic implants today announces its fourth 510(k) clearance to market auxiliary liners.
The auxiliary liners include a 10-degree, hooded, and +4mm liners. This additional array of implants fully compliments the acetabular liners already available, providing the surgical alternatives required in today’s demanding environment.
“The continued development of such products demonstrates the commitment Iconacy has to serve our customers while we maintain our made in USA commitment. Our surgeon developers will continue to provide unmatched design features and we are committed to produce them here.” “This team has developed a great solution. We look forward to producing, delivering, and providing patients this solution”, says Tom Allen, President and CEO.
As noted in the indications for use, the I-Hip system consists of porous coated femoral stem and acetabular cup components intended for cementless, press-fit fixation.
ICONACY is an entrepreneurial orthopedic company started by seasoned professionals with a view focusing on the needs of patients, surgeons, and hospitals without the bureaucracy and costly infrastructure of larger organizations. ICONACY will produce all of its product in the United States which will include hip, knee, and shoulder joint replacements. The commitment to U.S. based manufacturing demonstrates a long-term view toward quality and efficiency. Moreover, ICONACY is committed to providing best-in-class service to its customers, ultimately driving patient care and efficiency through the orthopedic market. ICONACY will do this by providing individualized service levels at the hospital setting while eliminating inefficiencies within the traditional supply chain.
ICONACY SAFE HARBOR STATEMENT
This press release contains forward looking statements within the safe harbor provisions of Securities Litigation Reform Act of 1995. Forward looking statements can be identified by such terms as “may”, “will”, “expects”, “believes”, “forecasts”, “targets”. These or any other statements are not guarantees of future performance. Readers of this should not place undue reliance on forward-looking statements.